Calcifediol is the form of vitamin D that circulates in your bloodstream and serves as the body’s main marker of vitamin D status. When your doctor orders a “vitamin D level” blood test, they’re measuring calcifediol. Chemically known as 25-hydroxyvitamin D3, it’s produced in the liver when your body processes the vitamin D you get from sunlight, food, or supplements. It’s also available as a prescription medication for specific conditions where standard vitamin D supplements fall short.
How Your Body Makes Calcifediol
Vitamin D3 (cholecalciferol), whether made in your skin from sun exposure or absorbed from food, isn’t biologically active on its own. It first travels to the liver, where enzymes add a chemical group to it in a process called hydroxylation. The result is calcifediol. This step happens primarily through an enzyme called CYP2R1, though a second enzyme (CYP27A1) contributes as well.
Calcifediol then binds to a carrier protein in the blood called vitamin D binding protein, which shuttles it throughout the body. From there, the kidneys perform a second conversion, turning calcifediol into calcitriol, the fully active hormone form of vitamin D. Calcitriol is what directly regulates calcium absorption, bone metabolism, and immune function. So calcifediol sits in the middle of the vitamin D pathway: it’s the product of liver processing and the raw material the kidneys need to produce the active hormone.
Why Doctors Measure It
Because calcifediol is the most abundant form of vitamin D in the blood and has a long half-life of roughly 10 to 17 days, it gives the most reliable snapshot of your overall vitamin D status. The standard reference ranges most experts use are:
- Deficient: below 20 ng/mL
- Insufficient: 21 to 29 ng/mL
- Sufficient: 30 ng/mL or above
That said, the Endocrine Society’s 2024 clinical guidelines suggest against routine vitamin D blood testing for the general population, noting there isn’t clear evidence defining an optimal target level for disease prevention. Testing is still appropriate when a specific medical condition calls for it, such as chronic kidney disease, osteoporosis, or malabsorption disorders.
Calcifediol as a Medication
Beyond being something your body produces naturally, calcifediol is also a prescription drug. In the United States, the FDA approved an extended-release formulation called Rayaldee for adults with stage 3 or 4 chronic kidney disease who have secondary hyperparathyroidism and vitamin D levels below 30 ng/mL. The typical starting dose is one 30-microgram capsule taken once daily at bedtime.
Secondary hyperparathyroidism happens when damaged kidneys can’t efficiently convert calcifediol into calcitriol. Without enough active vitamin D hormone, the parathyroid glands ramp up production of parathyroid hormone (PTH) in an attempt to maintain calcium levels. Over time, this leads to bone loss and other complications. Clinical trials have shown that standard vitamin D3 supplements are ineffective at controlling this problem, while Rayaldee’s extended-release design gradually raises calcifediol levels and restores calcitriol production without causing dangerous spikes in blood calcium or phosphorus.
Calcifediol is also sometimes prescribed off-label for osteomalacia, a softening and weakening of the bones caused by liver disease. Because the liver is where vitamin D3 gets converted into calcifediol, people with significant liver damage may not be able to make enough on their own. Taking calcifediol directly bypasses that broken step.
How It Compares to Standard Vitamin D3
Most over-the-counter vitamin D supplements contain cholecalciferol (vitamin D3), which your liver still needs to convert into calcifediol. When researchers compared the two head-to-head across nine randomized trials, calcifediol was about 3.2 times more potent at raising blood levels. At daily doses under 25 micrograms, each microgram of calcifediol raised blood levels by 4.8 nmol/L, compared to just 1.5 nmol/L per microgram of cholecalciferol.
Calcifediol also works faster. After oral dosing, it reaches peak blood concentrations within about 9 to 28 hours, and because it skips the liver conversion step, it doesn’t depend on liver enzyme activity to become useful. This speed and potency matter most in two situations: when someone needs to correct a deficiency quickly, and when a condition like obesity, celiac disease, or inflammatory bowel disease reduces intestinal absorption. Calcifediol has a higher absorption rate from the gut than cholecalciferol, which can make a meaningful difference for people whose digestive systems don’t absorb fat-soluble vitamins well.
For most healthy people, standard vitamin D3 supplements are perfectly effective. Calcifediol’s advantages become clinically important mainly for those with kidney disease, liver disease, or malabsorption conditions where the normal vitamin D pathway is impaired.
Side Effects and Risks
The primary safety concern with calcifediol, as with any form of vitamin D, is hypercalcemia: too much calcium in the blood. Because calcifediol is significantly more potent than regular vitamin D3, the margin for error is narrower. Symptoms of hypercalcemia include nausea, excessive thirst, frequent urination, confusion, and muscle weakness.
In clinical trials of the extended-release formulation for kidney disease, however, the risk of hypercalcemia was low. The slow-release design avoids the sharp blood level spikes that more potent vitamin D compounds can cause. Patients using prescription calcifediol typically have their blood calcium, phosphorus, and vitamin D levels monitored regularly to catch any imbalance early.